Skip to main content

Diffuse in-stent restenosis (ISR) in long-stented segment in the superficial femoral artery (SFA)

Case takeaways

  • The use of the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface* provides an excellent treatment option for ISR in the SFA, particularly when it involves a long stented segment
  • Atherectomy can be used as an adjunct to provide debulking of the restenotic tissue, and optimize stent graft expansion


*PROPATEN Bioactive Surface is synonymous with the CBAS Heparin Surface.

The outcomes and observations reported are based on individual case experience and the patients treated. The steps described here may not be complete, and are not intended to be a replacement for the Instructions for Use or the education, training and professional judgment of Healthcare Providers. Healthcare Providers remain solely responsible for making decisions about patient care and the use of medical technologies.

Visit our clinical uses page